• about axogen
    • management team
    • board of directors
    • careers
    • partners
    • esg report
    • code of ethics and conduct
    • patents
  • investors
  • news
  • contact
    • find a rep
    • international distributors
    • find referring surgeon
  • healthcare professionals
  • patients
COVID-19 Statement A letter from our CEO
Investors
  • Overview
  • News / Events
    • Overview
    • Press Releases
    • Axogen In the News
    • IR Calendar
    • ESG Report
    • Clinical Conferences
    • Presentations
    • Email Alerts
  • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
  • Stock Data
    • Current Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Contact the Board
  • Additional Info
    • Contacts
    • FAQ
  • Investor Tools
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

Press Releases

Axogen, Inc. Reports Preliminary Revenue for the First Quarter 2020, Provides Business Update in Response to COVID-19 Pandemic, and Announces Dismissal of Class Action Lawsuit

Apr 23, 2020

Axogen, Inc. to Report First Quarter 2020 Financial Results and Host Conference Call on May 6, 2020

Apr 15, 2020

Axogen, Inc. to Participate at Upcoming Investor Conferences

Mar 2, 2020

Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results

Feb 24, 2020

Axogen, Inc. to Present at the Leerink Partners 9th Annual Global Healthcare Conference

Feb 5, 2020

Axogen, Inc. to Report Fourth Quarter and Full-Year 2019 Financial Results and Host Conference Call on February 24, 2020

Feb 3, 2020

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2019 and Provides 2020 Annual Guidance

Jan 13, 2020

Axogen Sponsored RANGERĀ® Registry Reaches 2,000 Nerve Repair Enrollment Milestone

Jan 8, 2020

Axogen to Participate at AAHS ASPN ASRM 2020 Annual Meetings

Jan 2, 2020

Axogen, Inc. to Participate at JP Morgan 38th Annual Healthcare Conference

Jan 2, 2020
RSS
    • 1...
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • ...29
    Next

    13631 Progress Blvd, Suite 400
    Alachua, FL 32615

    • contact
    • careers
    • Privacy Policy
    • Terms of Use
    • Legal Notices
    • Instagram Logo
    • Twitter Logo
    • Linkedin Logo
    • Facebook Logo

    © 2023 Axogen Corporation. The stylized "a" logo, Revolutionizing the Science of Nerve Repair and Avance Nerve Graft are trademarks of Axogen Corporation.

    Top

    You are now leaving axogeninc.com

    Axogen is not responsible for content or policies on linked sites.